RBC Life Sciences, Inc.

RBC Life Sciences, Inc.

RBCL
RBC Life Sciences, Inc.US flagOther OTC
0.00
USD
- -
- -
1,549.00Market Cap

RBC Life Sciences, Inc. (RBCL) Stock Split History

Learn about RBC Life Sciences, Inc.'s most recent 1-for-10 basis stock split on August 12, 2013. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about RBC Life Sciences, Inc.'s most recent stock split

Split Date: 2013-08-12
Split Ratio: 1:10
Price Before Split: $0.17
Price After Split: $0.02

Developer API

Get RBCL split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/RBCL

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 10.00 times fewer shares (a 1:10 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of RBC Life Sciences, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2013-08-121:10Yes$0.17$0.02
1997-04-171:7YesN/AN/A

About RBC Life Sciences, Inc.

Company overview and industry information

RBC Life Sciences, Inc. (RBCL) operates in the Medical - Pharmaceuticals industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Medical - Pharmaceuticals
Go to RBC Life Sciences, Inc. Summary

Last updated: 7/21/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.